clofibrate has been researched along with Brain Vascular Disorders in 27 studies
angiokapsul: contains clofibrate & insoitolnicotinate
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (92.59) | 18.7374 |
| 1990's | 1 (3.70) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| OLIVER, MF | 2 |
| Fujioka, T | 1 |
| Ueno, T | 1 |
| Matsumoto, T | 1 |
| Watanabe, H | 1 |
| Bousser, MG | 1 |
| Lechner, H | 1 |
| Ott, E | 1 |
| Bertha, G | 1 |
| Hanefeld, M | 1 |
| Hora, C | 1 |
| Schulze, J | 1 |
| Rothe, G | 1 |
| Barthel, U | 1 |
| Haller, H | 1 |
| Birgens, HS | 1 |
| Hansen, MS | 1 |
| Hirsh, J | 5 |
| Cristol, R | 1 |
| Olivella, J | 1 |
| Vicens, B | 1 |
| Turpie, AG | 2 |
| Smith, GD | 1 |
| Egger, M | 1 |
| Sheldon, TA | 1 |
| Weiss, HJ | 1 |
| Dettori, AG | 1 |
| Pini, M | 1 |
| Quintavalla, R | 1 |
| Gantmacher, ML | 1 |
| Blakely, JA | 1 |
| Harker, LA | 2 |
| Gent, M | 3 |
| Genton, E | 3 |
| Aledort, LM | 1 |
| Zöllner, N | 1 |
| Keller, C | 1 |
| Wolfram, G | 1 |
| Parsons, WB | 1 |
| Miettinen, TA | 1 |
| Huttunen, JK | 1 |
| Naukkarinen, V | 1 |
| Strandberg, T | 1 |
| Vanhanen, H | 1 |
| Hirsch, SB | 1 |
| Wechsler, AF | 1 |
| Tourtellotte, WW | 1 |
| Hammer, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000482] | Phase 3 | 0 participants | Interventional | 1965-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for clofibrate and Brain Vascular Disorders
| Article | Year |
|---|---|
[Dyslipidemia in renal failure].
Topics: Arteriosclerosis; Cerebrovascular Disorders; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Coronar | 2004 |
Strategy of reducing coronary risk and the use of drugs.
Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Cerebrovascular Disorders; Cholesterol; Clofibra | 1984 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofib | 1983 |
Therapeutical aspects of cerebrovascular disease.
Topics: Aspirin; Blood Coagulation; Cerebrovascular Disorders; Clofibrate; Dipyridamole; Erythrocyte Aggrega | 1983 |
[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Dextrans; | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Di | 1981 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyr | 1981 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Hea | 1981 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coro | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofi | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Platelets and thromboembolism.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Dext | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Diso | 1975 |
10 trials available for clofibrate and Brain Vascular Disorders
| Article | Year |
|---|---|
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofib | 1983 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Di | 1981 |
Plafibride: clinical trial of a new platelet antiaggregating agent.
Topics: Adenosine Diphosphate; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Clofib | 1981 |
Drug therapy: antiplatelet therapy (second of two parts).
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical T | 1978 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Clofibrate and niacin in coronary heart disease.
Topics: Adult; Arterial Occlusive Diseases; Cerebrovascular Disorders; Cholesterol; Clinical Trials as Topic | 1975 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Surviva | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Diso | 1975 |
Long-term use of probucol in the multifactorial primary prevention of vascular disease.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Cerebrovascular Disorders; Cholesterol, HDL; C | 1986 |
Clofibrate for the treatment of occlusive cerebrovascular disease.
Topics: Adult; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Humans; Middle Aged; P | 1972 |
7 other studies available for clofibrate and Brain Vascular Disorders
| Article | Year |
|---|---|
ATROMID-S AND ATROMID.
Topics: Androsterone; Arteriosclerosis; Butyrates; Cerebrovascular Disorders; Clofibrate; Coronary Disease; | 1964 |
Reduced incidence of cardiovascular complications and mortality in hyperlipoproteinemia (HLP) with effective lipid correction. The Dresden HLP study.
Topics: Adolescent; Adult; Cerebrovascular Disorders; Cholesterol; Cholestyramine Resin; Clofibrate; Combine | 1984 |
Cholesterol reduction and stroke.
Topics: Cerebrovascular Disorders; Cholesterol; Clofibrate; Humans; Male; Meta-Analysis as Topic; Middle Age | 1994 |
Platelet suppressing drugs in arterial disease.
Topics: Anticoagulants; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Humans; Myocardial | 1978 |
[Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
Topics: Angina Pectoris; Cerebrovascular Disorders; Cholesterol; Clofibrate; Delayed-Action Preparations; Fo | 1976 |
Hyperlipidemia: to treat or not to treat.
Topics: Cerebrovascular Disorders; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Humans; Hyper | 1975 |
[Gerontotherapy in a clinical sanatorium with Gerostop].
Topics: Aged; Calcium; Cerebrovascular Disorders; Clofibrate; Drug Combinations; Health Resorts; Humans; Nic | 1972 |